Globulin, immune - PharmaKB

Globulin, immune

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

10012 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Neoplasms	D009369	—	C80	915	446	23	5	36	1146
Lymphoma	D008223	—	C85.9	399	499	75	5	34	865
Carcinoma	D002277	—	C80.0	321	512	92	1	53	844
Non-small-cell lung carcinoma	D002289	—	—	280	309	82	2	19	557
Lung neoplasms	D008175	HP_0100526	C34.90	200	259	80	2	21	462
Breast neoplasms	D001943	EFO_0003869	C50	203	248	52	3	29	460
Leukemia	D007938	—	C95	209	236	32	1	19	427
Covid-19	D000086382	—	—	50	95	53	14	242	424
Recurrence	D012008	—	—	174	269	28	2	14	417
Colorectal neoplasms	D015179	—	—	190	210	20	3	28	368

Show 325 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Melanoma	D008545	—	—	203	183	16	—	14	336
Adenocarcinoma	D000230	—	—	107	179	30	—	10	279
B-cell lymphoma	D016393	—	—	159	145	13	—	10	270
Squamous cell carcinoma	D002294	—	—	86	154	29	—	12	239
Pancreatic neoplasms	D010190	EFO_0003860	C25	145	123	7	—	11	228
Ovarian neoplasms	D010051	EFO_0003893	C56	127	119	20	—	8	228
Squamous cell carcinoma of head and neck	D000077195	—	—	109	127	21	—	9	212
Large b-cell lymphoma diffuse	D016403	—	C83.3	106	123	12	—	6	205
Renal cell carcinoma	D002292	EFO_0000376	—	117	103	9	—	6	196
B-cell chronic lymphocytic leukemia	D015451	—	C91.1	103	111	13	—	4	195

Show 327 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Burkitt lymphoma	D002051	—	C83.7	28	30	—	—	1	48
Pancreatic ductal carcinoma	D021441	—	—	22	20	—	—	3	37
Myeloproliferative disorders	D009196	—	D47.1	17	18	—	—	2	32
Myelomonocytic leukemia juvenile	D054429	—	C93.3	19	17	—	—	1	32
Plasmablastic lymphoma	D000069293	—	C83.3	18	21	—	—	1	32
Large-cell lymphoma immunoblastic	D016400	—	—	18	21	—	—	1	32
Myelomonocytic leukemia chronic	D015477	—	C93.1	18	16	—	—	1	30
T-cell leukemia	D015458	—	—	12	16	—	—	1	26
Central nervous system neoplasms	D016543	—	—	16	11	—	—	3	24
Lymphomatoid granulomatosis	D008230	—	C83.8	13	16	—	—	1	24

Show 492 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Hypothyroidism	D007037	EFO_0004705	E03.9	1	—	—	—	6	7
Lyme disease	D008193	—	A69.2	1	—	—	—	3	4
Substance-related disorders	D019966	EFO_0003890	F13	1	—	—	—	3	4
Hyperplasia	D006965	EFO_0000536	—	1	—	—	—	3	4
Cutaneous lupus erythematosus	D008178	EFO_0003834	L93.1	4	—	—	—	—	4
Cerebral infarction	D002544	—	I63	2	—	—	—	1	3
Bone diseases	D001847	—	M89.9	1	—	—	—	2	3
Endocrine gland neoplasms	D004701	EFO_0003769	D35	2	—	—	—	1	3
Yellow fever	D015004	—	A95	2	—	—	—	1	3
Zika virus infection	D000071243	—	A92.5	3	—	—	—	—	3

Show 109 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Syphilis	D013587	EFO_0007504	A53.9	—	—	—	—	9	9
Irritable bowel syndrome	D043183	EFO_0000555	K58	—	—	—	—	8	8
Autonomic nervous system diseases	D001342	EFO_0009532	G90	—	—	—	—	5	5
Enterocolitis	D004760	EFO_1001481	—	—	—	—	—	5	5
Vaccine immunogenicity	D000071497	—	—	—	—	—	—	5	5
Atrophic gastritis	D005757	EFO_1000826	K29.4	—	—	—	—	4	4
Myocarditis	D009205	—	I51.4	—	—	—	—	4	4
Hiv testing	D000082922	—	—	—	—	—	—	4	4
Sarcoidosis	D012507	EFO_0000690	D80-D89	—	—	—	—	4	4
Venom hypersensitivity	D000092422	—	—	—	—	—	—	3	3